BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

ビジネス · 2002/3/151 分で読めます

Topical Antifungal Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph; Correction

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 8, 2002 (67 FR 5942). The document amended the final monograph for over-the-counter (OTC) topical antifungal drug products to add the ingredient clotrimazole as generally recognized as safe and effective for the treatment of athlete's foot, jock itch, and ringworm. The document was inadvertently published with an incorrect docket number. This document corrects that error.

情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →

関連インサイト

ビジネスインサイト →